{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:22:52Z","timestamp":1778620972602,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["212102310184"],"award-info":[{"award-number":["212102310184"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011841","name":"Xinxiang Medical University","doi-asserted-by":"publisher","award":["QN-2022- A06"],"award-info":[{"award-number":["QN-2022- A06"]}],"id":[{"id":"10.13039\/501100011841","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.intimp.2023.110480","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T11:40:37Z","timestamp":1687174837000},"page":"110480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Anti-interleukin 33 treatment alleviates psoriatic dermatitis in mice induced imiquimod"],"prefix":"10.1016","volume":"121","author":[{"given":"Dandan","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zishan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangfeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2023.110480_b0005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110480_b0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jdermsci.2019.07.006","article-title":"Anti-IL-17A and IL-23p19 antibodies but not anti-TNFalpha antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis","volume":"95","author":"Shimizu","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2023.110480_b0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/CCID.S257647","article-title":"IL-33\/13 axis and IL-4\/31 axis play distinct roles in inflammatory process and itch in psoriasis and atopic dermatitis","volume":"13","author":"Bodoor","year":"2020","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110480_b0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.110480_b0025","doi-asserted-by":"crossref","first-page":"7158014","DOI":"10.1155\/2019\/7158014","article-title":"Possible roles of IL-33 in the innate-adaptive immune crosstalk of psoriasis pathogenesis","volume":"2019","author":"Cannavo","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"Pt A","key":"10.1016\/j.intimp.2023.110480_b0030","article-title":"Effects of IL-33 on 3T3-L1 cells and obese mice models induced by a high-fat diet","volume":"101","author":"Kai","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110480_b0035","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/exd.12027","article-title":"IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation","volume":"21","author":"Balato","year":"2012","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110480_b0040","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jid.2020.07.027","article-title":"An autocrine circuit of IL-33 in keratinocytes is involved in the progression of psoriasis","volume":"141","author":"Zeng","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110480_b0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/ced.12670","article-title":"Serum IL-33 levels are increased in patients with psoriasis","volume":"41","author":"Mitsui","year":"2016","journal-title":"Clin. Exp. Dermatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110480_b0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00403-016-1675-2","article-title":"IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo","volume":"308","author":"Vaccaro","year":"2016","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.intimp.2023.110480_b0055","first-page":"179","article-title":"Evaluating serum levels of IL-33, IL-36, IL-37 and gene expression of IL-37 in patients with psoriasis vulgaris","volume":"17","author":"Sehat","year":"2018","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.intimp.2023.110480_b0060","doi-asserted-by":"crossref","unstructured":"Y. Dong, H. Hu, D. Fu, S. Zheng, Q. Wang, C.K. K, X. Song, Z. Tian, Serum Expression of IL-33 and ST2 in Patients with Psoriasis Vulgaris, Arch Iran Med 24(9) (2021) 689-695.","DOI":"10.34172\/aim.2021.99"},{"key":"10.1016\/j.intimp.2023.110480_b0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cyto.2019.02.019","article-title":"IL-33 contributes to disease severity in Psoriasis-like models of mouse","volume":"119","author":"Duan","year":"2019","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.intimp.2023.110480_b0070","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1073\/pnas.1000803107","article-title":"IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin","volume":"107","author":"Theoharides","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.intimp.2023.110480_b0075","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/eji.201041360","article-title":"IL-33 induces skin inflammation with mast cell and neutrophil activation","volume":"41","author":"Hueber","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110480_b0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2249.2012.04618.x","article-title":"Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor","volume":"169","author":"Suttle","year":"2012","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110480_b0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00403-010-1046-3","article-title":"A comparison of Ki-67 antigen presentation in acute generalized exanthematous pustulosis and pustular psoriasis","volume":"302","author":"Chang","year":"2010","journal-title":"Arch. Dermatol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2023.110480_b0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/exd.12128","article-title":"Studies of Jak\/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity","volume":"22","author":"Andres","year":"2013","journal-title":"Exp. Dermatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110480_b0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00011-019-01238-8","article-title":"Proinflammatory and anti-inflammatory cytokine profiles in psoriasis: use as laboratory biomarkers and disease predictors","volume":"68","author":"Cataldi","year":"2019","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110480_b0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jid.2020.04.031","article-title":"Induction of regulatory T cells and correction of cytokine disbalance by short-chain fatty acids: implications for psoriasis therapy","volume":"141","author":"Schwarz","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"22","key":"10.1016\/j.intimp.2023.110480_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228560","article-title":"TLR2 deficiency exacerbates imiquimod-induced psoriasis-like skin inflammation through decrease in regulatory T cells and impaired IL-10 production","volume":"21","author":"Nakao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2023.110480_b0110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/jamadermatol.2015.2","article-title":"Immunologic overlap of helper T-cell subtypes 17 and 22 in erythrodermic psoriasis and atopic dermatitis","volume":"151","author":"Moy","year":"2015","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.intimp.2023.110480_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.788940","article-title":"The role of helper T cells in psoriasis","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110480_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: A STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2023.110480_b0125","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41419-019-1510-8","article-title":"Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2023.110480_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114041","article-title":"Qinzhuliangxue mixture alleviates psoriasis-like skin lesions via inhibiting the IL6\/STAT3 axis","volume":"274","author":"Qu","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110480_b0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bjd.12049","article-title":"STAT1 expression and activation is increased in lesional psoriatic skin","volume":"168","author":"Hald","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110480_b0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/jid.2010.255","article-title":"Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor","volume":"131","author":"Miyoshi","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.110480_b0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.intimp.2015.12.035","article-title":"Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice via Jak3\/Stat3 signaling pathway","volume":"32","author":"Di","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.110480_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109747","article-title":"Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2\/STAT3 signal pathways","volume":"123","author":"Yuan","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.intimp.2023.110480_b0155","doi-asserted-by":"crossref","first-page":"e2344","DOI":"10.1038\/cddis.2016.201","article-title":"Luteolin-7-glucoside inhibits IL-22\/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model","volume":"7","author":"Palombo","year":"2016","journal-title":"Cell Death Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923008032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923008032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:55:59Z","timestamp":1778619359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923008032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":31,"alternative-id":["S1567576923008032"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110480","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-interleukin 33 treatment alleviates psoriatic dermatitis in mice induced imiquimod","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110480"}}